Phage Display Synthetic Libraries Construction

Service Overview

A synthetic antibody library is first a sequence-design problem, then a construction problem. Creative Biolabs defines framework sequence(s), antibody format, CDR or residue-level diversification, amino-acid distributions, encoding rules, and exclusion criteria around the downstream screening question, then translates that design into a phage display antibody library.

The main constraint is physical representation: theoretical sequence space can expand far beyond what can be synthesized, assembled, transformed, recovered, and displayed. We therefore balance design breadth with realistic library representation and plan QC around the features that matter for later selection and interpretation.

Which Antibody Library Strategy Fits Your Project?

Synthetic construction is most useful when deliberate control of the search space matters more than preserving a natural immune repertoire. The comparison below helps route projects to the library strategy that best matches the biological starting material and discovery objective.

Library Strategy comparison table
Library Strategy	Diversity Source	Best Fit
Immune Library	Antigen-experienced repertoire	Capture an immunized or antigen-exposed response
Naïve Library	Non-immunized natural repertoire	Broad discovery from natural repertoire diversity
Semi-Synthetic Library	Natural + designed diversity	Retain selected biological sequence information while redesigning defined regions
Synthetic Library	Designed sequence space	Control framework, CDR positions, residue distributions, and encoding from the outset

If the project starts from natural sequences that should remain part of the library, a semi-synthetic route may be more appropriate. When no suitable immune material is available, or when a reusable and tightly controlled search space is the priority, a fully synthetic design can provide a clearer starting point.

Our Synthetic Antibody Library Design Service

Creative Biolabs designs the library around the sequence space the project needs to explore and the physical representation that can realistically be achieved. Framework, antibody format, CDR positions, amino-acid distributions, encoding, exclusion rules, and VH/VL pairing are defined together rather than as isolated choices.

Design Variable comparison table
Design Variable	How We Design It
Framework Selection	A single framework, a focused framework panel, or another agreed scaffold strategy is selected based on antibody format, expression and display requirements, and the intended target application.
Antibody Format	We choose scFv, Fab, V_HH where appropriate, or another agreed architecture, with chain organization, assembly requirements, and display constraints considered together.
CDR Diversification	CDRs or individual residue positions are selected for diversification according to the search objective and the sequence space that can be realistically represented.
Amino-Acid Distribution	Equal, biased, natural-like, restricted, or position-specific residue distributions can be specified as needed, rather than leaving composition to codon degeneracy alone.
Encoding Strategy	We match degenerate oligonucleotides, trinucleotide-based synthesis, oligonucleotide pools, or another encoding approach to the required sequence control, synthesis feasibility, and stop-codon or indel risk.
Sequence Exclusion Rules	Selected motifs, premature stops, highly hydrophobic patterns, reactive residues, or other project-relevant features can be restricted when there is a clear design rationale. These restrictions refine the search space but do not by themselves establish developability.
VH/VL Pairing Strategy	For two-chain formats, both chains may be diversified broadly, or one chain, framework family, or pairing set may be constrained. Pair diversity is then considered against realistic physical library representation.

Library Qualification Against the Design

Qualification compares the recovered library with the design specification rather than treating clone count as a proxy for usable diversity. We distinguish the theoretical design space, recovered physical population, sequence-observed diversity, and display-competent subset so each layer is evaluated on its own evidence.

Framework and construct fidelity. Verify nondiversified framework residues, structural junctions, insert integrity, and productive reading frame.
Designed-position fidelity. Compare observed amino-acid frequencies with the intended matrix and assess premature stops, indels, or recurrent synthesis and assembly skew.
Diversity and representation. Assess unique sequence recovery, redundancy, and high-frequency outliers while keeping physical clone recovery separate from observed sequence diversity.
Amplification stability. When included in scope, compare checkpoints to identify sequence classes that expand or disappear during propagation.
Display competence. Confirm that sequence-correct antibody fragments are presented in the selected phage system and identify design classes that may be underrepresented after display.

For designs that require deeper characterization, phage display NGS analysis can provide a broader view of realized sequence distributions than limited clone sampling alone.

Optional Downstream Screening

Qualified libraries can continue into phage display library screening and biopanning. Selection can use purified-antigen, competitive, subtractive, cell-based, or another project-suitable format, with target presentation and known off-targets used to define the selection strategy.

After enrichment, sequences are interpreted against the starting library distribution and tested at clone level in assays appropriate to the target and fragment format. If a selected fragment is reformatted, the new construct should be retested rather than assuming that phage-displayed behavior will transfer unchanged.

Our Synthetic Library Construction Workflow

Synthetic Libraries Construction. (Creative Biolabs Original) — Fig.1 Synthetic libraries construction workflow at Creative Biolabs.

01
Library Design
Translate the project objective into framework, antibody format, diversification, pairing, and exclusion rules, with the intended screening context defined at the same stage.
02
Encoding and DNA Synthesis
Encode the amino-acid design using a synthesis strategy matched to the required distribution control, synthesis feasibility, and variable-pool complexity.
03
Variable Region Assembly
Assemble designed CDR or variable-region pools into the selected antibody-fragment architecture while preserving fixed framework residues and intended cloning junctions.
04
Cloning and Phage Display
Clone the assembled pool into the selected display system and recover the physical library under conditions chosen to limit avoidable representation loss.
05
Library Qualification
Evaluate the recovered library against the design specification before release or downstream screening.

Discuss Your Project

Project Inputs and Deliverables

Project Inputs

What to Send Us

Design basis
framework or scaffold concept, plus a parent antibody or sequence family when it should constrain the search space.
Diversity plan
CDRs or residue positions to diversify, intended amino-acid distributions, and any motifs or residues to exclude.
Library format
preferred antibody format and any VH/VL pairing constraints already defined.
Screening context
target format, selection objective, and relevant off-targets or negative controls.
QC expectations
desired clone-sampling or NGS depth for the downstream decision.

Project Outputs

What You Receive

Qualified library material
the constructed synthetic antibody phage display library after agreed release checks.
Physical library measurements
recovery metrics together with insert and assembly QC.
Sequence-level assessment
designed-versus-observed distributions, redundancy, and other agreed QC readouts at the selected depth.
Optional extended datasets
NGS outputs or display-related evidence when included in scope.
Technical report
the library design, construction, and QC results documented for downstream screening.

Published Data

Synthetic scFv phage display library design showing fixed human heavy- and light-chain frameworks, defined CDR3 randomization patterns, DNA assembly strategies, and cloning into the pHEN1 phagemid vector (OA Literature) — Fig.2 Framework-guided CDR3 diversification and assembly of a synthetic scFv phage display library.¹

Weber et al. described the design, construction, and characterization of PHILODiamond, a synthetic human scFv phage display library built on predefined germline frameworks with sequence diversity concentrated in the heavy- and light-chain CDR3 loops. The authors assembled the designed variable regions into a phagemid system and reported 4.1 x 10¹⁰ independent clones. Post-construction checks showed that more than 90% of randomly sampled unselected clones expressed scFv fragments and 93% carried an insert of the expected size, demonstrating why realized-library QC should be separated from the theoretical design space. Figure 2 is especially informative for synthetic library planning because it connects framework selection, defined CDR3 randomization, assembly, and cloning into one construction scheme. The study supports a central principle of synthetic library design: useful diversity depends not only on how many combinations are mathematically permitted, but also on how faithfully those combinations are synthesized, assembled, transformed, expressed, and displayed. Those layers should be measured separately before screening.

Reference 1 · Open-access literature

Frequently Asked Questions

How is a synthetic antibody library different from a semi-synthetic library?

A synthetic library defines its diversified sequence space through designed frameworks and/or CDR diversification without relying on direct capture of a natural repertoire for the variable diversity. A semi-synthetic library intentionally preserves some natural sequence information and combines it with designed diversity. The distinction should be made at the sequence-design level, not simply by the vector used for display.

Which CDRs should be diversified?

There is no universal set. The choice depends on framework, antibody format, target class, whether the project needs broad discovery or focused optimization, and how much combinatorial space can be physically sampled. Position-specific design is usually more defensible than indiscriminate randomization of every accessible residue.

Why is theoretical diversity not the same as library size?

Theoretical diversity counts the combinations allowed by the design. DNA synthesis, assembly, transformation, duplicate sequences, nonproductive inserts, expression, and phage display all reduce the fraction that is physically present and functionally displayed. Those layers should therefore be measured or estimated separately.

Can sequence liabilities be designed out of a synthetic library?

Selected motifs or residue classes can be restricted during sequence design when there is a clear scientific reason. That can reduce avoidable sequence space, but it does not establish manufacturability, stability, or developability of future binders. Those properties require candidate-level evaluation after selection.

Does a well-matched NGS distribution guarantee a successful screen?

No. NGS can show whether the constructed pool resembles the intended design and can reveal stops, indels, redundancy, or skew. It does not prove target binding. Screening success also depends on target presentation, selection pressure, negative controls, display behavior, and clone-level confirmation.

Reference

Weber, Marcel, et al. A Highly Functional Synthetic Phage Display Library Containing over 40 Billion Human Antibody Clones. PLOS ONE 9.6 (2014): e100000. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1371/journal.pone.0100000.